Efficacy of Multiple Modified Methods of Criteria for LR‐MLiver Nodules of Different Sizes

To assess the diagnostic performance of the modified LR‐M method of CEUS LI‐RADS version 2017 with nodules of different sizes. This retrospective study included consecutive patients with high risk for HCC who underwent CEUS between 2019 and 2021, demonstrating an LR‐M observed using CEUS LI‐RADS version 2017. Four modified LR‐M methods were used to evaluate nodules of different sizes. The diagnostic performances of the four modified LR‐M methods were assessed in LR‐M nodules of different sizes by the area under the receiver operating characteristic curve (AUC). The 261 patients with LR‐M observations included 166 HCCs and 95 non‐HCCs. A total of 133 nodules were <30 mm and defined as group A, 78 nodules were 30–50 mm in size and defined as group B, and 50 nodules were >50 mm and defined as group C. The AUCs between criterion I, II, III, and IV were not significantly different in all LR‐M nodules. The AUCs of the ROC curves between criterion I, II, III, and IV were not significantly different in group A. However, the AUC of criterion IV was significantly higher than that of criterion I and III in group B, and the AUCs of criterion I and criterion III were both not significant in group B; the AUC of criterion IV was not significant in group C. The modified LR‐M method could moderate the detection effectiveness in differentiating HCC from other lesions. According to tumor size, the selection of appropriate modified LR‐M diagnostic criteria could effectively improve the diagnostic performance of LR‐M.